Alcohol intake, tobacco smoking, and esophageal adenocarcinoma survival: a molecular pathology epidemiology cohort study

Autor: Victoria Bingham, Manuel Salto-Tellez, R Stephen McCain, Eamon McCarron, Helen G Coleman, Chintapuza Chisambo, Stephanie G Craig, Eileen Parkes, Damian T. McManus, Stephen McQuaid, Richard C. Turkington, Nathan B. Reid, Jacqueline A James

Publikováno v: McCain, R S, McManus, D T, McQuaid, S, James, J A, Salto-Tellez, M, Reid, N B, Craig, S, Chisambo, C, Bingham, V, McCarron, E, Parkes, E, Turkington, R C & Coleman, H G 2020, ' Alcohol intake, tobacco smoking, and esophageal adenocarcinoma survival: a molecular pathology epidemiology cohort study ', Cancer Causes and Control, vol. 31, no. 1, pp. 1-11 . https://doi.org/10.1007/s10552-019-01247-2
Cancer Causes & Control

Purpose To investigate the association between cigarette smoking, alcohol consumption, and esophageal adenocarcinoma survival, including stratified analysis by selected prognostic biomarkers. Methods A population-representative sample of 130 esophage

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9feb1d24c680e0031cb59ff9dc8ebf54
https://doi.org/10.1007/s10552-019-01247-2

Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma

Autor: Martin Eatock, Christopher Steele, Kenneth Arthur, Fergus Noble, Shona MacRae, Leanne Stevenson, Eamon McCarron, Andrena McCavigan, Laura A. Knight, Timothy J. Underwood, Richard D. Kennedy, D. Paul Harkin, Eileen Parkes, Sophia Halliday, Maria Secrier, Ahmad Miremadi, Robert O'Neill, Rebecca C. Fitzgerald, Jan Bornschein, Manuel Salto-Tellez, Gemma E Logan, Steven Walker, Damian T. McManus, Jacqueline James, Rosalie Douglas, Jaine K. Blayney, Stephen McQuaid, Eilis K Sutton, Juliane Perner, Richard C. Turkington

Publikováno v: 2019, ' Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma ', Gut . https://doi.org/10.1136/gutjnl-2018-317624
Gut
Turkington, R, Knight, L, Blayney, J, Secrier, M, Douglas, R, Parkes, E, Sutton, E, Stevenson, L, McManus, D, Halliday, S, McCavigan, A, Logan, G, Walker, S, Steele, C, Perner, J, Bornscein, J, MacRae, S, Miremadi, A, McCarron, E, McQuaid, S, Arthur, K, James, J, Eatock, M, O'Neill, R, Noble, F, Underwood, T, Harkin, D, Salto-Tellez, M, Fitzgerald, R C & Kennedy, R 2019, ' Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma ', Gut, vol. 68, no. 11, pp. 1918-1927 . https://doi.org/10.1136/gutjnl-2018-317624

ObjectiveCurrent strategies to guide selection of neoadjuvant therapy in oesophageal adenocarcinoma (OAC) are inadequate. We assessed the ability of a DNA damage immune response (DDIR) assay to predict response following neoadjuvant chemotherapy in O

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23b146d2559bd473454602b6bce88d29